Home
About
Overview
Sharing Data
ORCID
Help
History (5)
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
AAV-Mediated Gene Therapy for Glycosphingolipid Biosynthesis Deficiencies.
Medication Therapy Management
Thalamic Nuclei
The association between inflammatory biomarkers and statin use among patients with head and neck squamous cell carcinoma.
See All 5 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
AAV-Mediated Gene Therapy for Glycosphingolipid Biosynthesis Deficiencies.
Yang H, Brown RH, Wang D, Strauss KA, Gao G. AAV-Mediated Gene Therapy for Glycosphingolipid Biosynthesis Deficiencies. Trends Mol Med. 2021 06; 27(6):520-523.
View in:
PubMed
subject areas
Dependovirus
Epilepsy
Genetic Therapy
Genetic Vectors
Hereditary Sensory and Autonomic Neuropathies
Humans
Phenotype
Recombinant Proteins
Sialyltransferases
Spastic Paraplegia, Hereditary
authors with profiles
Dan Wang PhD
Kevin Strauss MD
Robert H Brown MD, DPhil
Guangping Gao PhD